1Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension:The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology ( ESC ). Eur Heart J ,2007,28:1462-1536.
2Macfadyen RJ. The 2007 revised ESC/ESH Guidelines in the management of hypertension: clarifying individual patient care. J Hum Hypertens,2007,21:757-761.
3Williams B. Evolution of hypertensive disease: a revolution in guidelines. Lancet ,2006,368:6-8.
4Mackenzie DG, Forbes JF, Rutledge P. New guidelines on hypertension. Lancet ,2006,368:641-643.
5Cruickshank JM. New guidelines on hypertension. Lancet, 2006,368: 641-645.
3Brent M. Egan,Yumin Zhao, R. Neal Axon. US Trends in Prevalence, Awareness,Treatment, and Control of Hypertension, 1988-2008 [ J]. the Journal of the Merican Medical Association. 2010,303 (20) :2043- 2050.
4Carlos M. Ferrario, John M. Flack, John E. Strobeck, et al. Individualizing hypertension treatment with impedance cardiography : a meta-analysis of published trials [ J]. the Therapeutic Advances in Cardiovascular Disease. 2010,4( 1 ) :5-16.
5Nitesh Sood, Kurt M. Reinhart, William L. Baker. Combination therapy for the management of hypertension: A review of the evidence [J]. the American Journal of Health-System Pharmacy. 2010,67 ( 11 ) : 885 -894.
6Julius S, K jeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine [ J]. the VALUE randomised trial. 2004,363 : 2022-2031.
